| Name | Title | Contact Details |
|---|
GridApp Systems, Inc. is a New York, NY-based company in the Software & Internet sector.
Follett Software Company is a division of Follett Corporation, whose mission is to be the leading provider of educational solutions, services and products that empower schools, libraries, and colleges to help turn students into life-long learners
For over half a century, DRC has provided powerful and trusted software solutions to the Property & Casualty (P&C) insurance industry. Large carriers, small start-ups and MGAs alike in the United States and globally deploy DRC`s SaaS and onsite solutions to manage total written premium in excess of $7 billion. DRC`s cloud-based administration system expedites implementation, lowers costs and simplifies maintenance across insurance products. Our leading RS X Rating Platform allows business users who price risks and model products in Microsoft Excel® workbooks to create a version-controlled, web service process throughout the entire insurance ecosystem with minimal need for any programming resource. All DRC clients receive market-leading solutions, expert implementation and our commitment to deliver to their complete satisfaction.
LBMX Inc is a London, ON-based company in the Software & Internet sector.
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.